Top Midday Decliners

MT Newswires Live09-28

Seelos Therapeutics (SEEL) said late Thursday that its 2024 annual meeting of stockholders scheduled for Sept. 27 has been "postponed."

The postponement is because of an "anticipated lack of quorum, and to provide further time to solicit proxies from the company's stockholders."

Shares slumped 19%, with intraday trading volume at over 1.16 million compared with a daily average of about 498,000.

EnVVeno Medical (NVNO) said late Thursday that it priced a public offering of about 4.3 million common shares or pre-funded warrants at $3.50 per share, targeting gross proceeds of about $15 million.

Shares plunged 25% as intraday trading volume soared to over 1.85 million versus the stock's daily average of about 50,000.

Cassava Sciences (SAVA) shares fell nearly 13% after the company said late Thursday it has agreed to pay a $40 million penalty to settle a US Securities and Exchange Commission case against it over allegedly misleading statements made related to the results of a phase 2 trial for its Alzheimer's disease drug candidate.

More than 4.76 million shares traded intraday compared with a daily average of about 3.55 million.

Price: 4.05, Change: -0.95, Percent Change: -19.00

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2470037978?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-09-28 01:58","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2470037978","market":"hk","top_or_hot":-1,"title":"Top Midday Decliners","media":"MT Newswires Live","content":"<html><body><p> Seelos <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> (SEEL) said late Thursday that its 2024 annual meeting of stockholders scheduled for Sept. 27 has been \"postponed.\"</p><p>The postponement is because of an \"anticipated lack of quorum, and to provide further time to solicit proxies from the company's stockholders.\"</p><p>Shares slumped 19%, with intraday trading volume at over 1.16 million compared with a daily average of about 498,000.</p><p>EnVVeno Medical (NVNO) said late Thursday that it priced a public offering of about 4.3 million common shares or pre-funded warrants at $3.50 per share, targeting gross proceeds of about $15 million.</p><p>Shares plunged 25% as intraday trading volume soared to over 1.85 million versus the stock's daily average of about 50,000.</p><p>Cassava Sciences (SAVA) shares fell nearly 13% after the company said late Thursday it has agreed to pay a $40 million penalty to settle a US Securities and Exchange Commission case against it over allegedly misleading statements made related to the results of a phase 2 trial for its Alzheimer's disease drug candidate.</p><p>More than 4.76 million shares traded intraday compared with a daily average of about 3.55 million.</p><p>Price: 4.05, Change: -0.95, Percent Change: -19.00</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Top Midday Decliners</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTop Midday Decliners\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-09-28 01:58 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.mtnewswires.com/><strong>MT Newswires Live</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Seelos Therapeutics (SEEL) said late Thursday that its 2024 annual meeting of stockholders scheduled for Sept. 27 has been \"postponed.\"The postponement is because of an \"anticipated lack of quorum, ...</p>\n\n<a href=\"https://www.mtnewswires.com/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4588","symbol_name":"碎股","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2470037978","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2470037978","pubTimestamp":1727459893,"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Seelos Therapeutics  said late Thursday that its 2024 annual meeting of stockholders scheduled for Sept. 27 has been \"postponed.\"The postponement is because of an \"anticipated lack of quorum, and to provide further time to solicit proxies from the company's stockholders.\"Shares slumped 19%, with intraday trading volume at over 1.16 million compared with a daily average of about 498,000.EnVVeno Medical  said late Thursday that it priced a public offering of about 4.3 million common shares or pre-funded warrants at $3.50 per share, targeting gross proceeds of about $15 million.Shares plunged 25% as intraday trading volume soared to over 1.85 million versus the stock's daily average of about 50,000.Cassava Sciences  shares fell nearly 13% after the company said late Thursday it has agreed to pay a $40 million penalty to settle a US Securities and Exchange Commission case against it over allegedly misleading statements made related to the results of a phase 2 trial for its Alzheimer's dise","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4588":"碎股","SAVA":"Cassava Sciences Inc","NVNO":"enVVeno Medical Corp.","BK4007":"制药","BK4585":"ETF&股票定投概念","SEEL":"Seelos Therapeutics, Inc.","BK4082":"医疗保健设备","BK4547":"WSB热门概念"},"translate_title":"午盘跌幅最大的股票","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NVNO":0.9,"SAVA":0.9,"SEEL":0.9},"content_text":"Seelos Therapeutics (SEEL) said late Thursday that its 2024 annual meeting of stockholders scheduled for Sept. 27 has been \"postponed.\"The postponement is because of an \"anticipated lack of quorum, and to provide further time to solicit proxies from the company's stockholders.\"Shares slumped 19%, with intraday trading volume at over 1.16 million compared with a daily average of about 498,000.EnVVeno Medical (NVNO) said late Thursday that it priced a public offering of about 4.3 million common shares or pre-funded warrants at $3.50 per share, targeting gross proceeds of about $15 million.Shares plunged 25% as intraday trading volume soared to over 1.85 million versus the stock's daily average of about 50,000.Cassava Sciences (SAVA) shares fell nearly 13% after the company said late Thursday it has agreed to pay a $40 million penalty to settle a US Securities and Exchange Commission case against it over allegedly misleading statements made related to the results of a phase 2 trial for its Alzheimer's disease drug candidate.More than 4.76 million shares traded intraday compared with a daily average of about 3.55 million.Price: 4.05, Change: -0.95, Percent Change: -19.00","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2470037978"}